SGRY · Surgery Partners, Inc.
$15.75
-0.94% last session
End-of-day data · close of 2026-10-23
Market cap
$2B
Enterprise value
$8B
Trailing P/E
—
Forward P/E
56.3
Dividend yield
0.0%
Beta
1.91
Avg volume
2M
Employees
16K
Daily Change %
-0.94%
5 Days Change
8.83%
10 Days Change
9.28%
30 Days Change
9.20%
60 Days Change
13.98%
Month to Day Change
20.18%
Year to Day Change
2.91%
Analyst Outlook
Analyst estimates change daily — follow the shifts on the Estimate Trends page.
Technical Analysis
Analyst sentiment over time — SGRY
Rec Mean (blue, left — higher = more bullish) vs. price targets (right).
Investment Bank Ratings as of 2026-09-30
Latest call per bank · past 12 months
RBC Capital
Outperform$19.00
+20.6% vs priceJP Morgan
Neutral$15.00
-4.8% vs priceUBS
Buy$21.00
+33.3% vs priceBarclays
Equal-Weight$14.00
-11.1% vs priceRecent rating actions
| Date | Firm | Action | Rating | Price target |
|---|---|---|---|---|
| 2026-09-30 | RBC Capital | Reiterates | Outperform | $19.00 |
| 2026-09-18 | TD Cowen | Reiterates | Buy | $19.00 |
| 2026-09-14 | JP Morgan | Maintains | Neutral | $14.00 → $15.00 |
| 2026-08-11 | TD Cowen | Maintains | Buy | $17.00 → $19.00 |
| 2026-08-11 | RBC Capital | Maintains | Outperform | $20.00 → $19.00 |
| 2026-08-11 | Cantor Fitzgerald | Reiterates | Overweight | $18.00 |
| 2026-03-05 | TD Cowen | Maintains | Buy | $28.00 → $20.00 |
| 2026-03-05 | UBS | Maintains | Buy | $29.00 → $21.00 |
Ratings and price targets are the published opinions of the issuing banks, compiled from Yahoo Finance rating actions — not investment advice.
Signal Summary as of 2026-10-23
- neutral: RSI (14): RSI is 64 — neutral momentum, neither overbought nor oversold.
- bullish: Price vs 50-day MA: Trading 10.7% above the 50-day MA ($14.23).
- bullish: Price vs 200-day MA: Trading 9.1% above the 200-day MA ($14.44).
- bearish: MA cross: The 50-day MA sits below the 200-day MA (death-cross regime) — the longer-term trend points down.
- bullish: MACD (12,26,9): MACD histogram is positive (+0.21) — short-term momentum is improving.
- neutral: 52-week range: Price sits between the 52-week low ($11.49) and high ($22.94).
SGRY Price Chart
Loading chart for SGRY…
Fundamentals
About Surgery Partners, Inc.
Surgery Partners, Inc., together with its subsidiaries, owns and operates a network of surgical facilities and ancillary services in the United States. The company provides ambulatory surgery centers and surgical hospitals that offer non-emergency surgical procedures in various specialties, including orthopedics and pain management, ophthalmology, gastroenterology, and general surgery. It offers emergency departments; ancillary services such as physician practices and diagnostic testing; multi-specialty physician practices; urgent care facilities; and anesthesia services. In addition, it offers single- and multi-specialty facilities. Surgery Partners, Inc. was founded in 2004 and is headquartered in Brentwood, Tennessee.
More in Medical Care Facilities
HCA
HCA Healthcare, Inc.
$102B 0.6% YTD
THC
Tenet Healthcare Corporation
$22B 36.2% YTD
EHC
Encompass Health Corporation
$12B 19.6% YTD
DVA
DaVita Inc.
$12B 63.8% YTD
FMS
Fresenius Medical Care AG
$12B -2.9% YTD
UHS
Universal Health Services, Inc.
$11B -13.4% YTD
ENSG
The Ensign Group, Inc.
$10B 2.5% YTD
PACS
PACS Group, Inc.
$8B 23.7% YTD
Data is sourced from end-of-day snapshots and refreshed daily before the US market open — nothing on this page is real-time. Figures can contain vendor errors. This page is for information only and is not investment advice.